title: Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes.
abstract: In the course of familial investigations of coronary artery disease, we identified an extended kinship in which several members were affected with type IIa hyperlipoproteinemia (HLPIIa), type III dyslipoproteinemia (DLPIII), or hypobetalipoproteinemia (HBLP). To study the genetic defects responsible for plasma lipoprotein abnormalities in this pedigree and to investigate the phenotypic effect of different genotypic combinations, we used molecular markers for apolipoprotein (apo) B, apo E, and the low density lipoprotein (LDL) receptor to characterize segregation at each locus. Linkage analysis showed that elevated LDL cholesterol levels and the HBLP phenotype were due to defects at the LDL receptor and the apo B loci, respectively. One pedigree member, who inherited both an LDL receptor allele linked with elevated LDL cholesterol levels and an apo B allele linked with HBLP, had a normal lipoprotein phenotype. Seven patients who simultaneously inherited the defective LDL receptor allele and one or two apo E2 alleles manifested DLPIII. The E2 alleles in this pedigree were shown by DNA sequence analysis to be the common E2 158 (arginine----cysteine) allele. These findings suggested a possible interaction between the abnormal LDL receptor and apo E2 alleles, resulting in the expression of DLPIII in the presence of a single copy of ago E2.
authors.affiliation: Howard Hughes Medical Institute, University of Utah Health Sciences Center, Salt Lake City.
authors.forename: M
authors.initials: M
authors.lastname: Emi
authors.forename: R M
authors.initials: RM
authors.lastname: Hegele
authors.forename: P N
authors.initials: PN
authors.lastname: Hopkins
authors.forename: L L
authors.initials: LL
authors.lastname: Wu
authors.forename: R
authors.initials: R
authors.lastname: Plaetke
authors.forename: R R
authors.initials: RR
authors.lastname: Williams
authors.forename: J M
authors.initials: JM
authors.lastname: Lalouel
mesh_terms: D000293:Adolescent; D000328:Adult; D053329:Apolipoprotein E2; D053318:Apolipoprotein E3; D001057:Apolipoproteins E / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D008078:Cholesterol, LDL / Q000097:blood; D004247:DNA / Q000032:analysis; D005260:Female; D008040:Genetic Linkage; D005838:Genotype; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000235:genetics*; D007223:Infant; D008074:Lipoproteins / Q000235:genetics*; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D010641:Phenotype; D011110:Polymorphism, Genetic / Q000235:genetics; D011956:Receptors, Cell Surface / Q000235:genetics; D011973:Receptors, LDL / Q000235:genetics
chemical_list: D053329:Apolipoprotein E2; D053318:Apolipoprotein E3; D001057:Apolipoproteins E; D008078:Cholesterol, LDL; D008074:Lipoproteins; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011956:Receptors, Cell Surface; D011973:Receptors, LDL; D004247:DNA